MET and Hepatic fibrosis: HGFR activation via delivery of recombinant HGF or HGF-expressing plasmids and stem cells decreases lethal liver failure, prevents hepatocyte apoptosis, protects hepatocytes against oxidative injury, and decreases liver fibrosis [2,3,5,25].